Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127512471 | 12751247 | 1 | I | 20151230 | 20160905 | 20160915 | 20160915 | EXP | FR-PFIZER INC-2016418229 | PFIZER | 72.00 | YR | F | Y | 66.00000 | KG | 20160915 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127512471 | 12751247 | 1 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous drip | 2 MG DAILY, CYCLIC | 71484 | 2 | MG | ||||||||
| 127512471 | 12751247 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | 15 MG DAILY, CYCLIC | U | 11719 | 15 | MG | |||||||
| 127512471 | 12751247 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Subcutaneous | 1400 MG DAILY, CYCLIC | 0 | 1400 | MG | ||||||||
| 127512471 | 12751247 | 4 | SS | DOXORUBICIN TEVA | DOXORUBICIN | 1 | Intravenous drip | 81 MG DAILY, CYCLIC | 0 | 81 | MG | ||||||||
| 127512471 | 12751247 | 5 | SS | ENDOXAN /00021101/ | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 1220 MG DAILY, CYCLIC | 0 | 1220 | MG | ||||||||
| 127512471 | 12751247 | 6 | SS | CORTANCYL | PREDNISONE | 1 | Oral | 100 MG DAILY, CYCLIC | 0 | 100 | MG | ||||||||
| 127512471 | 12751247 | 7 | SS | METHYLPREDNISOLONE MYLAN /00049602/ | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 80 MG, DAILY | 0 | 80 | MG | ||||||||
| 127512471 | 12751247 | 8 | C | POLARAMINE | DEXCHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 127512471 | 12751247 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Intravenous drip | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 127512471 | 12751247 | 10 | C | ONDANSETRON ACCORD | ONDANSETRON | 1 | Intravenous drip | 8 MG, UNK | 0 | 8 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127512471 | 12751247 | 1 | B-cell lymphoma |
| 127512471 | 12751247 | 2 | B-cell lymphoma |
| 127512471 | 12751247 | 3 | B-cell lymphoma |
| 127512471 | 12751247 | 4 | B-cell lymphoma |
| 127512471 | 12751247 | 5 | B-cell lymphoma |
| 127512471 | 12751247 | 6 | B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127512471 | 12751247 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127512471 | 12751247 | Acute prerenal failure | |
| 127512471 | 12751247 | Campylobacter gastroenteritis | |
| 127512471 | 12751247 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127512471 | 12751247 | 1 | 20151221 | 0 | ||
| 127512471 | 12751247 | 2 | 20151221 | 0 | ||
| 127512471 | 12751247 | 3 | 20151221 | 0 | ||
| 127512471 | 12751247 | 4 | 20151221 | 0 | ||
| 127512471 | 12751247 | 5 | 20151221 | 0 | ||
| 127512471 | 12751247 | 6 | 20151222 | 20151225 | 0 | |
| 127512471 | 12751247 | 7 | 20151221 | 0 | ||
| 127512471 | 12751247 | 8 | 20151221 | 0 | ||
| 127512471 | 12751247 | 9 | 20151221 | 0 | ||
| 127512471 | 12751247 | 10 | 20151221 | 0 |